skip to primary navigationskip to content
 

Menna Clatworthy receives an EFIS-IL Lecture Award

last modified Jul 01, 2019 03:58 PM
Menna Clatworthy, a Group Leader in the University of Cambridge Molecular Immunity Unit based at the LMB, has won a prestigious EFIS-IL Lecture Award.

Menna Clatworthy receives an EFIS-IL Lecture Award

Menna Clatworthy

Menna Clatworthy, a Group Leader in the University of Cambridge Molecular Immunity Unit based at the LMB, has won a prestigious EFIS-IL (European Federation of Immunological Societies-Immunology Letters) Lecture Award, having been described by the nominating body as “a true clinician scientist of the 21st century – continuously pushing boundaries of biomedical insight at the interface of fundamental immunology, clinical immunology and systems precision medicine”.

The EFIS-IL Lecture Award enables EFIS Member Societies to invite an outstanding European immunologist to speak at their national meeting, where the recipient is presented with a bronze medal depicting two early pioneers of immunology, Paul Ehrlich and Elie Metchnikoff.

Menna’s group are interested in understanding how activation of B cells and the function of antibodies are regulated in different parts of the body, particularly in the kidney and the gut, and how they influence immune responses. Menna’s lecture on her research in this area had a major focus on work from her group recently published in the journal Immunitythat has led to a new understanding of the cause of ulcerative colitis (UC). Her team identified how having a genetic variant of a particular type of antibody receptor leads to UC. This variant alters antibody binding such that immune cells may be inappropriately activated by antibodies binding to bacteria that are naturally found in our gut. Importantly, these findings challenged previous assumptions that IgG antibodies are unimportant in the gut, where IgA is the more common type of antibody, and potentially identifies a new pathway that can be targeted for UC treatment.

About receiving the award, Menna said,

“I was hugely honoured to be nominated for this award and even more pleased to receive it, especially when I looked at previous laureates, many of whom I view as giants of immunology – Adrian Hayday, Klaus Rajewski, Luke O’Neill and Marco Colonna to name a few. Hopefully I can emulate their achievements going forward.”

Menna has previously been awarded the British Renal Association Raine Award and the Medical Research Society Young Investigator Award for her work on the role of antibodies and Fcg receptors in auto-immunity and defence against infection. Menna divides her time between research, teaching, and clinical practice in transplantation and nephrology.

Menna received her award at the Scandinavian Society of Immunology Annual General Meeting in Norway.

Menna’s group page

EFIS-IL Lecture Award

 

The MRC Laboratory of Molecular Biology (LMB), Published 

The new Capella building- CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Capella building will be finished in 2019.

Fibroblast

‘Fibroblast’ has been developed from a conversation between Harold Offeh and Dr Alice Denton, a scientist based at the Babraham Institute and a member of the Cambridge Immunology Network. Offeh was particularly interested in the character and roles played by particular cells in the immune system, as well as the immune system’s role as a primary source of protection and care. The film takes as a starting point microscopic images of broblast cells, an area of research for Dr Denton.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more